Iris Pharma

Overview

• Assessing possible therapeutic effect in ocular diseases
• Adding value to promising drug candidates or medical devices
• Designing development plans and preclinical packages and carrying out studies to proceed with confidence from bench to bedside
• Providing the comprehensive clinical development services you need, from First-in-Human through Phase IV and Post-marketing follow-through

Iris Pharma's a la carte services include: 

• in vivo screening
• Proof of concept studies
• Ocular efficacy studies
• GLP preclinical studies
• Bioanalytical testing services
• Clinical trials and clinical research services
• Post marketing surveys

We accompany start-up companies, biotechnology companies, large pharmaceutical companies, pharmaceutical labs, universities, research organizations and consultants in their ophthalmology projects.

Our assets: 

• 30 years of experience in the field of ophthalmology research
• All ophthalmic indications mastered
• 70 FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations
• State-of-the-art medical and scientific equipment
• Highly specialized and qualified staff
• CIR agreement
  

Standards & Methodologies

Iris Pharma has not posted any Methodologies at this time.

Qualifications, Certifications, Accreditations & Licenses

Iris Pharma has not posted any Certifications, Accreditations or Licenses at this time.